{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:08:48Z","timestamp":1784020128028,"version":"3.55.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,14]]},"DOI":"10.7759\/cureus.112634","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:52:17Z","timestamp":1784019137000},"source":"Crossref","is-referenced-by-count":0,"title":["Reversible HIV-Associated Nephropathy and Concomitant Encephalomyelopathy as the Initial Presentation of Advanced, Untreated HIV"],"prefix":"10.7759","author":[{"given":"Mya","family":"Ya Minn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Qasim","family":"Umer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew  Chisom","family":"Madu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Stacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Sujith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2008.08.005","article-title":"HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy","volume":"28","author":"Wyatt CM","year":"2008","unstructured":"Wyatt CM, Klotman PE, D'Agati VD. HIV-associated nephropathy: clinical presentation, pathology, and epidemiology in the era of antiretroviral therapy. Semin Nephrol. 2008, 28:513-22. 10.1016\/j.semnephrol.2008.08.005","journal-title":"Semin Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr3235w","article-title":"HIV-associated nephropathy in Africa: pathology, clinical presentation and strategy for prevention","volume":"10","author":"Husain NE","year":"2018","unstructured":"Husain NE, Ahmed MH, Almobarak AO, et al.. HIV-associated nephropathy in Africa: pathology, clinical presentation and strategy for prevention. J Clin Med Res. 2018, 10:1-8. 10.14740\/jocmr3235w","journal-title":"J Clin Med Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000526868","article-title":"HIV-associated nephropathy in 2022","volume":"3","author":"Rivera FB","year":"2023","unstructured":"Rivera FB, Ansay MF, Golbin JM, et al.. HIV-associated nephropathy in 2022. Glomerular Dis. 2023, 3:1-11. 10.1159\/000526868","journal-title":"Glomerular Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: a working proposal","volume":"43","author":"D'Agati VD","year":"2004","unstructured":"D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004, 43:368-82. 10.1053\/j.ajkd.2003.10.024","journal-title":"Am J Kidney Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106283442604","article-title":"Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection","volume":"344","author":"Winston JA","year":"2001","unstructured":"Winston JA, Bruggeman LA, Ross MD, et al.. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med. 2001, 344:1979-84. 10.1056\/NEJM200106283442604","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328357f5ed","article-title":"Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care","volume":"26","author":"Kalayjian RC","year":"2012","unstructured":"Kalayjian RC, Lau B, Mechekano RN, et al.. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS. 2012, 26:1907-15. 10.1097\/QAD.0b013e328357f5ed","journal-title":"AIDS"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system","volume":"65","author":"Letendre S","year":"2008","unstructured":"Letendre S, Marquie-Beck J, Capparelli E, et al.. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008, 65:65-70. 10.1001\/archneurol.2007.31","journal-title":"Arch Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-020-00295-y","article-title":"Human immunodeficiency virus-associated vacuolar encephalomyelopathy with granulomatous-lymphocytic interstitial lung disease improved after antiretroviral therapy: a case report","volume":"17","author":"Akagi K","year":"2020","unstructured":"Akagi K, Yamamoto K, Umemura A, et al.. Human immunodeficiency virus-associated vacuolar encephalomyelopathy with granulomatous-lymphocytic interstitial lung disease improved after antiretroviral therapy: a case report. AIDS Res Ther. 2020, 17:38. 10.1186\/s12981-020-00295-y","journal-title":"AIDS Res Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834171f8","article-title":"Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort","volume":"25","author":"Smurzynski M","year":"2011","unstructured":"Smurzynski M, Wu K, Letendre S, et al.. Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS. 2011, 25:357-65. 10.1097\/QAD.0b013e32834171f8","journal-title":"AIDS"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/509637-reversible-hiv-associated-nephropathy-and-concomitant-encephalomyelopathy-as-the-initial-presentation-of-advanced-untreated-hiv","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:52:18Z","timestamp":1784019138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/509637-reversible-hiv-associated-nephropathy-and-concomitant-encephalomyelopathy-as-the-initial-presentation-of-advanced-untreated-hiv"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.112634","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,14]]}}}